Sage Therapeutics Inc Inc. (SAGE) Price Performance: The Role of Supply and Demand

Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. Year to date metric has recorded a loss of -49.10%.However, over the last six months, we can see a stronger performance of -56.06%. Over the last 30 days, the price of SAGE has fallen by 4.25%. And in the last five days, it has surged by 1.94%.

The market performance of Sage Therapeutics Inc has been somewhat unstable. Over the past year, the company’s stock achieved a high of $49.74 on 07/12/23, with the lowest value for the same timeframe being $9.76, recorded on 06/11/24.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

52-week price history of SAGE Stock

A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Sage Therapeutics Inc’s current trading price is -77.82% away from its 52-week high, while its distance from the 52-week low is 13.01%. The stock’s price range over this timeframe has been between $9.76 and $49.74. The shares of the Healthcare sector company recorded a trading volume of approximately 0.71 million for the day, which was comparatively lower than the average daily volume of 1.33 million over the last three months.

The Connection Between Financial Performance and Market Capitalization

Sage Therapeutics Inc (SAGE) has experienced a quarterly decline of -33.23% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 663.79M and boasts a workforce of 487 employees.

How Moving Averages and Trading Volume Data Work Together

Based on Barchart.com data, the company’s moving average over the 100-day period was 15.15, with a change in price of -14.72. Similarly, Sage Therapeutics Inc recorded 1,154,428 in trading volume during the last 100 days, posting a change of -57.17%.

SAGE’s Debt-to-Equity Ratio: A Comprehensive Review

A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for SAGE stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.

SAGE Stock Stochastic Average

The raw stochastic average for Sage Therapeutics Inc over the last 50 days is presently at 25.66%. This reflects a drop from the raw stochastic average of the previous 20 days, which was noted at 53.36%. Further, the company’s Stochastic %K and %D values for the last 20 days were 58.26% and 51.96%, respectively.

Most Popular